Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2025-12-24 @ 4:50 PM
NCT ID:
NCT03701750
Eligibility Criteria:
Inclusion Criteria:
* ≥2 consecutive IVF/ICSI-ET without clinical pregnancy
* ≥2 oocytes retrieval cycles
* 19\<BMI≤25
* Normal ovarian reserve ( AMH\> 1, FSH \<10 )
* Willing and able to sign the informed consent.
Exclusion Criteria:
* Uterine abnormalities confirmed by hysterosalpingography or hysteroscopy
* Parental chromosomal abnormalities
* PCOS
* Anti-phospholipid Syndrome
* Endocrine disorder
* Endometriosis
* Hydrosalpinx
* Chronic disease (liver, renal, thyroid, and thrombocytopenia)
* Regular anticoagulation or antiplatelet treatment
* Patients who had contraindication for unfractionated heparin therapy
* History of tuberculosis, HIV, HBV, HCV or tests indicating carriage of HBV or HCV, or positive interferon-gamma release assay in any of the couple
* Enrollment in another clinical trial
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
38 Years
Study:
NCT03701750
Study Brief:
Protocol Section:
NCT03701750